Table 1 Demographic and clinical data of the 18 patients.
Parameter | Transumbilical approach (n = 14) | Transcesarean section scar approach (n = 4) | Total (n = 18) |
|---|---|---|---|
Sex (m/f) | 7/7 | 0/4 | 7/11 |
Age (years) | 51.14 ± 14.87 | 35.75 ± 6.40 | 47.72 ± 14.82 |
BMI | 23.61 ± 2.54 | 24.98 ± 4.92 | 23.92 ± 3.09 |
Common bile duct diameter (mm) | 10.50 (9.00,15.00) | 9.00 (8.25,9.75) | 10.00 (9.00,12.75) |
Number of extrahepatic bile duct stones (single/multiple) | 4/10 | 2/2 | 6/12 |
Maximum stone diameter (mm) | 5.00 (4.00,8.25) | 6.00 (4.25,7.75) | 5.00 (4.00,8.00) |
Preoperative albumin (g/L) | 40.35 (36.25,43.80) | 41.30 (39.08,42.03) | 41.10 (37.38,43.05) |
Preoperative bilirubin (µmol/L) | 19.25 (13.89,58.58) | 14.94 (11.02,58.10) | 17.55(12.57,58.58) |
Preoperative alkaline phosphatase (U/L) | 143.3 (113.75,251.53) | 119.9 (79.95,180.25) | 138.60 (95.60,236.53) |
Preoperative HGB (g/L) | 128.00 (119.00,135.25) | 130.50 (122.25,137.25) | 130 (119.75,135.25) |
Combined residual gallstones in the gallbladder [n(%)] | 1 (7.14) | 0 (0.00) | 1 (5.56) |
History of LC [n(%)] | 1 (7.14) | 0 (0.00) | 1 (5.56) |
History of pancreatitis [n(%)] | 3 (21.43) | 0 (0.00) | 3 (16.67) |
History of cholangitis [n(%)] | 3 (21.43) | 0 (0.00) | 3 (16.67) |